Results 81 to 90 of about 8,514 (172)

Policy recommendations for promoting nuclear medicine therapy in Japan 2025, from the Working Group for promoting nuclear medicine therapy of the Japan Society of Clinical Oncology. [PDF]

Int J Clin Oncol
Suzuki K, Miyake H, Inaki A, Takano S, Kuboki Y, Mizowaki T, Nakamura K, Ueno M, Matsumoto S, Obinata D, Nakagawa T, Murakami M, Majima Y, Yokono M, Namba M, Yoshino T.   +15 more
europepmc   +1 more source

Tumour control, eye retention and visual acuity after radiotherapy for choroidal melanoma. [PDF]

BMJ Open Ophthalmol
Murtagh P, O'Riordan MM, O'Neill V, Cunningham M, D'Arcy F, Eleuteri A, Greene A, Baily C, Kennedy S, Hussain R, Heimann H, Horgan N.   +11 more
europepmc   +1 more source

Dose-effect relationship of D90 in iodine-125 seed implantation for advanced lung cancer: gradient-based efficacy and survival outcome. [PDF]

BMC Cancer
Cao G, Di X, Liu X, Wang Z, Xu K, Chang X, Wang J, Zhang H.   +7 more
europepmc   +1 more source

Trends in metastatic thyroid cancer survival from 1992 to 2022: a SEER database analysis. [PDF]

Endocr Oncol
Govindan A, Costa PA, Feinn R, Deshpande H.   +3 more
europepmc   +1 more source

Secondary primary tumors following iodine-125 low-dose-rate brachytherapy for localized prostate cancer. [PDF]

Int J Clin Oncol
Niwa K, Iinuma K, Nakano M, Tomioka M, Ito M, Mori T, Kawase K, Taniguchi T, Tobisawa Y, Nakane K, Matsuo M, Koie T.   +11 more
europepmc   +1 more source

Long-Term Variations in ¹²⁹I Seawater Concentrations off Fukushima and Potential of ¹²⁹I as an Oceanographic Tracer for ALPS-Treated Water. [PDF]

Environ Sci Technol
Suzuki T, Otosaka S, Takata H, Kuwabara J, Nakanishi T, Ikenoue T.   +5 more
europepmc   +1 more source

Applying Lean Six Sigma to improve efficiency in outpatient iodine-131 therapy: reducing process time and material waste. [PDF]

BMJ Open Qual
Jani S, Murray M, Kramer D, Thawani N, Diaz A, Sorensen S.   +5 more
europepmc   +1 more source

Positive prognostic implications of SPHK1 expression in patients with papillary thyroid carcinoma undergoing radioactive iodine therapy. [PDF]

Sci Rep
Park KW, Bae JS, Lim DJ, Jung CK.
europepmc   +1 more source

Salivary and lacrimal disorders in patients treated with radioiodine for differentiated thyroid cancer. [PDF]

Eur Thyroid J
Bondet de La Bernardie S, Bernier MO, Buffet C, Lussey-Lepoutre C, Baudin C.   +4 more
europepmc   +1 more source

Radionuclide Selection Influences Imaging Outcomes in Immuno-PET with a Brain-Penetrating Anti-Amyloid-β Antibody. [PDF]

J Nucl Med
Lopes van den Broek S, Bratteby K, Aguilar X, Tran TA, Syvänen S, Sehlin D.   +5 more
europepmc   +1 more source